Clinical Trials Directory

Trials / Completed

CompletedNCT01716819

Role of the Renin Angiotensin Aldosterone System in the Mechanisms of Transition to Heart Failure in Abdominal Obesity

Role of the Renin Angiotensin Aldosterone System and Remodeling of the Matrix Cardiac Extra Cellular in the Mechanisms of Transition to Heart Failure in Abdominal Obesity: Prospective Longitudinal Study R2C2 II

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
101 (actual)
Sponsor
Central Hospital, Nancy, France · Academic / Other
Sex
All
Age
43 Years – 72 Years
Healthy volunteers
Accepted

Summary

R2C2 study has shown that abdominal obesity is associated with a cardiac and vascular remodelling in healthy volunteers. This remodelling is correlated with renin-angiotensin aldosterone system (RAAS) activation and/or systemic fibrosis. R2C2 II study is designed to confirm the hypothesis that RAAS is associated with an early remodelling and implicated in the transition to cardiac failure in abdominal obesity.

Detailed description

Follow up of abdominal obesity patients from the R2C2 cohort study.

Conditions

Interventions

TypeNameDescription
OTHERUrine sampledosages on one spot and 24h collection
OTHERBlood sampledosages
OTHERAssessment of sleep apnea syndrome
OTHERElectrocardiogram
OTHERGlucose tolerance test
OTHEREchocardiography
OTHERcardiac and abdominal magnetic resonance imaging
OTHERAmbulatory blood pressure monitoring
OTHEREchotracking
OTHERPulse wave velocity
OTHERComposition of body mass by Dual x-ray absorptiometry

Timeline

Start date
2012-11-01
Primary completion
2015-03-01
Completion
2015-03-01
First posted
2012-10-30
Last updated
2015-08-24

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT01716819. Inclusion in this directory is not an endorsement.